Salix Pharmaceuticals Ltd. (SLXP) shares surged 15.5% after The Wall Street Journal claimed that Allergan Inc. (AGN) has approached Salix to acquire it. Salix also touched a 52-week high of $162.38 during the trading session on Aug 19.
The Wall Street Journal also claimed that Allergan’s decision to bid for Salix is to hinder Valeant Pharmaceuticals International Inc.’s (VRX) proposal to acquire Allergan.
The Wall Street Journal also claimed that Allergan’s decision to bid for Salix is to hinder Valeant Pharmaceuticals International Inc.’s (VRX) proposal to acquire Allergan.
more on salix
Aucun commentaire:
Enregistrer un commentaire